Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Australian Ovarian Cancer Study (AOCS)

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma'. Together they form a unique fingerprint.

Physics & Astronomy

Medicine & Life Sciences

Chemical Compounds